Trial Profile
Phase 1 study of human atrial natriuretic peptide during perioperative period for completely resected colorectal cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Aug 2020
Price :
$35
*
At a glance
- Drugs Carperitide (Primary)
- Indications Acute heart failure; Colorectal cancer
- Focus Adverse reactions
- 02 Aug 2020 Status changed from active, no longer recruiting to completed.
- 29 Jan 2018 Status changed from recruiting to active, no longer recruiting.
- 28 Jan 2018 Planned number of patients changed from 6 to 7.